Replies to post #1186 on NightHawk Biosciences Inc (NHWK)

[dia76ca]

I think the company wants everyone to see how great the ComPACT + checkpoint inhibitor data is before they release the ImPACT bladder and lung cancer data! I expect the 4 sets of data will also be very good. But they want investors and potential partners to know that the second generation ComPACT technology is even greater! Combine the great data with the fact that these vaccines can be mass produced at only a few hundred dollars a dose and HEAT has a bright future...if they partner...or if they are bought out! I could be wrong but I expect all 4 data sets in the next 3 1/2 weeks.

[Titan V]

This was just posted on Seeking Alpha.
http://seekingalpha.com/article/4023267-roche-bristol-face-bladder-cancer-threats

Merck could deliver knockout punches to BMY and Roche in multiple cancer indications by working together on an HTBX + ONCS Keytruda combo.